We're introducing a new look for GreyStone
Healthcare providers understand: if a patient’s immune system is not functioning properly, it can result in a variety of undesirable conditions, such as autoimmunity, allergy, and even cancer. It is also now becoming clear that immune responses contribute to the development of many common disorders not traditionally viewed as immunologic—including metabolic, cardiovascular, and neurodegenerative conditions such as Alzheimer’s.
Fast and accurate diagnosis of primary immunodeficiencies (PIDs) can be life-saving. Certain defects necessitate prompt medical responses, and many PIDs require personalized follow-up and supportive care to improve the outcome of affected patients. The information provided by GreyStone’s genetic testing allows providers to better inform affected individuals and families about prognosis and optimal surveillance strategies, and may also guide therapy.
Through cutting-edge genetic testing, we can help you determine a patient’s risk factors based on their DNA, so you can mitigate future consequences by taking steps now.
A precision-based genetic diagnosis of immunodeficiency can be a critical component in characterizing a variety of rare diseases. Genetic immunology testing can also improve treatment and follow-up strategies for affected patients and their families.
Moreover, identifying at-risk family members makes it possible for providers to develop early preventive treatments and/or lifestyle recommendations. These tests may also help make the case for routine follow-ups by healthcare professionals, and genetic diagnosis of immunodeficiencies can even support family planning.